Journal Papers :

Corresponding author X6

1.    F. H. Chen, C. S. Chiang, C. C. Wang, S. Y. Fu, C. S. Tsai, S. M. Jung, C. J. Wen, C. C. Lee, and J. H. Hong* Vasculatures in Tumors Growing from Preirradiated Tissues: Formed by Vasculogenesis and Resistant to Radiation and Antiangiogenic Therapy. Int. J. Radiat. Oncol. Biol. Phys., 2011,  80: 1512-1521 (SCI)

2.  Y. T. Huang, C. C. Wang, C. S. Tsai, C. H. Lai, T. C. Chang, H. H. Chou, S. Hsueh, C. K. Chen, S. P. Lee and J. H. Hong*  Long term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definite radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 2011,  80: 429-436 (SCI)

3.   C. C. Wang, C. H. Lai, H. J. Huang, A. Chao, C. J. Chang, T. C. Chang, H. H. Chou and J. H. Hong* Clinical Impact of Human Papillomavirus Genotypes in Patients with Cervical Cancer Undergoing Primary Radiotherapy.  Int. J. Radiat. Oncol. Biol. Phys.,  78: 1111-1120, 2010 (SCI)

4.    C. S. Tsai, C. H. Lai, T. C. Chang, T. C. Yen,  K. K. Ng, S. Hsueh, and J. H. Hong* A prospective randomized trial to study the impact of pre-treatment FDG-PET for cervical cancer patients with positive pelvic nodes but negative para-aortic node shown on MRI .  Int. J. Radiat. Oncol. Biol. Phys., 76: 477-484, 2010 (SCI)

5.    K. H. Fan, Y. C. Chen, C. K. Chuang, M. L. Hsieh and J. H. Hong*: Adjuvant androgen deprivation therapy loses its therapeutic benefit after premature termination: an experience of combined modality treatment on prostate cancer. Chang Gung Med. J. 32: 526-534, 2009

6.    F. H. Chen, C. S. Chiang, C. C. Wang, C. S. Tsai, S. M. Jung, C. C. Lee, W. H. McBride, and J. H. Hong*: Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors.  Clin. Cancer Res. 15:1721-1729, 2009 (SCI  IF=6.488)

Coauthor X 16

1.     S. C. Wang, J. H. Hong, C. Hsueh, and C. S. Chiang Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model. Lab Invest. 2011, In press  (SCI)

2.     K. C. Ho, C. C. Wang, J. T. Qiu, C. H. Lai, J. H. Hong, Y. T. Huang, K. G. Huang, A. Chao, G. lin and T. C. Yen  Identification of prognostic factors in patients with cervical cancer and supraclavicular lymph node recurrence, Gynecol. Oncol. 2011, In press, (SCI)

3.    J. J. Chen, J, J. Jason Chen, C. S. Chiang, J. H. Hong, C. K. Yeh Assessment of tumor vasculature for diagnostic and therapeutic applications in a mouse model in vivo using 25-MHz power Doppler imaging, Ultrasonics, 2011, 51: 925-931 (SCI)

4.     S. C. Wang, C. C. Wu, Y. Y. Wei, J. H. Hong, C. S. Chiang  Inactivation of ataxia telangiectasia mutated gene can increase intracellular reactive oxygen species levels and alter radiation-induced cell death pathways in human glioma cells. Int J Radiat Biol. 2011, 87:432-42 (SCI)

5.    L. H. Hsu, Y. P. Chen, H. P. Chang, Y. R. Chen, J. H. Hong, A. Chao, C. H. Successful salvage treatment of recurrent endometrial cancer with multiple lung and abdominal metastases. Eur J Gynaecol Oncol. 2011;32:218-20 (SCI)

6.     W. C. Cheng, M. L. Tsai, C. W. Chang, C. L. Huang, C. R. Chen, W. Y. Shu,Y. S. Lee, T. H. Wang, J. H. Hong, C. Y. Li and I. C. Hsu. Microarray meta-analysis database (M(2)DB): a uniformly pre-processed, quality controlled, and manually curated human clinical microarray database.  BMC Bioinformatics. 11:421, 2010 (SCI)

7.     H. H. Chou, H. P. Chang, C. H. Lai, K. K. Ng, S. Hsueh, T. I. Wu, M. Y. Chen, T. C. Yen, J. H. Hong and T. C. Chang 18F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma. Eur J Nucl Med Mol Imaging. 37: 728-735, 2010 (SCI)

8.    F. Y. Liu, T. C. Yen, M. Y. Chen, C. H. Lai, T. C. Chang, H. H. Chou, J. H. Hong, Y. R.Chen and K. K. Ng  Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.  Cancer, 115: 5470-5480, 2009 (SCI)

9.    T. M. Huang, J. H. Hong, W. M. Leung, C. Y. Lin, D. L. Tsa and N. M. Tsang Radiation therapy for advanced hepatocellular carcinoma with hepatic hilum involvement and high bilirubin level: better survival in decreased bilirubin after radiotherapy.  Therapeutic Radio. Oncol. (R. O. C.), 16: 179-194, 2009

10.         D. I. Tsan, J. H. Hong, N. M. Tsang, C. H. Chen and S. Y. Lin : Treatment outcome and pattern of failure in patients with Hodgkin’s lymphoma treated with radiotherapy: a single institution’s experience.  Therapeutic Radio. Oncol. (R. O. C.), 16: 85-97, 2009

11.         T. C. Chao, A. M. Chen, S. J. Tu, C. J. Tung, J. H. Hong and C. C. Lee   Evaluation of 6 and 18 MeV electron beams for small animal Iirradiation.  Phys. Med. Biol.,  54: 5847-5860, 2009 (SCI  IF=2.784)

12.M. H. Lin, T. C. Chao, C. C. Lee, C. J. Tung, C. Y. Yeh and J. H. Hong Measurement-Based Monte Carlo Dose Calculation System for IMRT Pre-treatment and In-vivo Dose Verifications.  Med. Phys, 36:1167-75, 2009 (SCI  IF=3.871)

13. W. C. Liu, W. L. Chuang, M. L. Tsai, J. H. Hong, W. H. McBride and C. S. Chiang.  Cordyceps sinensis health supplement enhances recovery from Taxol-induced leucopenia.  Exp. Biol. Med., 233:447-455, 2008 (SCI)

14.A. Chao , T. H. Wang, Y. S. Lee, J. H. Hong, C. N. Tsai , C. K.Chen, C. S. Tsai, A. S. Chao, C. H. Lai:  Analysis of functional   groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res. 169:76-86, 2008 (SCI)

15. C. S. Chiang, F. H. Chen, J. H. Hong, P. S. Jiang, H. L. Huang, C. C. Wang and W. H. McBride: Functional phenotype of macrophages depends on assay procedures, Int. Immunology, 20:215-22. 2008 (SCI)

16.  T. C. Yen, L. C. See , C. H. Lai, C. S. Tsai, A. Chao, S. Hsueh, J. H. Hong, T. C. Chang and K. K. Ng. Standardized uptake value in para-aortic lymph nodes is a significant prognostic factor in patients with primary advanced squamous cervical cancer. Eur J Nucl Med Mol Imaging. 35:493-501, 2008 (SCI).